- Bevorzugter Name
- 2-{4-[4-Pyridin-4-YL-1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-3-YL]-phenoxymethyl}-quinoline
- IUPAC
- 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline
- Englischer Name
- 2-{4-[4-Pyridin-4-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline
- Summenformel
- C26H19F3N4O
- Molmasse
- 460.45
Namen und Synonyme
TP-10898563-00-32-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline2-{4-[4-PYRIDIN-4-YL-1-(2,2,2-TRIFLUORO-ETHYL)-1H-PYRAZOL-3-YL]-PHENOXYMETHYL}-QUINOLINETp102-((4-(4-(pyridin-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl)phenoxy)methyl)quinolineSubstituted pyrazolesubstituted pyrazole, 13CHEMBL562513orb1308996SCHEMBL3270782SCHEMBL29368113
Weitere Namen anzeigen
TP-10, 10 mM in DMSO2-({4-[4-(4-Pyridinyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl]p henoxy}methyl)quinolineQuinoline, 2-[[4-[4-(4-pyridinyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl]phenoxy]methyl]-schizophrenia,U-87 MG,TP 10,cGMP,TP10,inhibit,TP-10,disorder,Inhibitor,cAMP,reactive oxygen,Phosphodiesterase (PDE),pCREB-LI
BDBM31596GTPL13575MFCD17167072AKOS030526976CS-5242HY-14550MS-28441DB-346642
Datenbank-Bezeichner
- ChEMBL
CHEMBL562513- Nikkaji
- J3.550.486I